Redeye provides a comment on Nanologica following the announcement of another order (marking the fou...
Redeye comments on the news that Egetis has decided to explore RTH-beta as the next indiction for ti...
Redeye is encouraged by the significant margin improvement achieved in the second quarter.
Redeye sees a Q2 report in line with our sales expectations but a bit heavier on the cost side.
Redeye leaves a comment following the promising recent interim data from Faron’s BEXMAB study and in...
BeammWave announced a joint pre-study with Alpha Networks, a fixed wireless access (FWA) challenger,...
Minor estimate revisions Subscription business performed well.
Contemplates issuance of SEK 250m bond (500m framework) Refinance of the SEK 250m bond issued in Q4'...
Sales of SEK 49m -38% q-o-q, EBIT back to negative at SEK -8m We lower FY'24/25e-FY'26/27e sales by ...
AcuCort har publicerat bolagets delårsrapport för det tredje kvartalet 2024 och annonserat en företr...
Ytterst positivt studieresultat Efter kvartalets slut meddelade bolaget att fas 1b-studien med STA36...
STENOCARE announced on December 2nd that the company’s premium product, the Astrum oil, has been app...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) har under och efter utgången av...
Ramlösa shipping AB (”Ramlösa” eller ”Bolaget”) har hållit ett högt affärstempo under det tredje kva...
Redeye comments on Gapwaves' joint venture agreement with Bosch and revised its estimates and fair v...
Redeye has a positive view of Tagmaster’s acquisition.
Divests four service-oriented Infra units for SEK 714m consideration Accelerates transition to highe...
VBG Group rapporterade en organisk tillväxtminskning på 11,5 % jämfört med Q3-23, med en omsättning ...
Tangiamo Touch Technology (”Tangiamo” eller ”bolaget”) publicerade den 29 november 2024 bolagets del...
Redeye provides a research update following the Q3 report published by Initiator Pharma earlier toda...
